Expression of microRNAs: potential molecular link between obesity, diabetes and cancer (Q37902256)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on 19 July 2011

Language	Label	Description	Also known as
English	Expression of microRNAs: potential molecular link between obesity, diabetes and cancer	scientific article published on 19 July 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

1 reference

Europe PubMed Central

Expression of microRNAs: potential molecular link between obesity, diabetes and cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

0 references

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

author name string

A S Ali

1

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

S Ali

2

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

B Bao

4

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

P A Philip

5

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

F H Sarkar

6

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

publication date

19 July 2011

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Obesity Reviews

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

1050-1062

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Exercise in weight management of obesity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Adipokines: inflammation and the pleiotropic role of white adipose tissue

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Increased visceral fat and impaired glucose tolerance predict the increased risk of metabolic syndrome in Japanese middle-aged men.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Cellular proliferation, apoptosis and angiogenesis: molecular targets for nutritional preemption of cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Obesity, type 2 diabetes and risk of digestive cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Cellular metabolic stress: considering how cells respond to nutrient excess.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Aging and inflammation: etiological culprits of cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Time course of risk factors in cancer etiology and progression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Sedentary Behavior and Cancer: A Systematic Review of the Literature and Proposed Biological Mechanisms

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Epidemiological aspects of neoplasms in diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Diabetes and cancer: a consensus report.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Impact of age, sex, and comorbidity on cancer therapy and disease progression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

New insulins and the risk of cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Obesity, adipocytokines, and insulin resistance in breast cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Adiponectin, type 2 diabetes and the metabolic syndrome: lessons from human genetic studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Interaction between adiponectin and leptin influences the risk of colorectal adenoma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

IL-1 family in breast cancer: potential interplay with leptin and other adipocytokines

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

HNF1B and JAZF1 genes, diabetes, and prostate cancer risk

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Genetic susceptibility to type 2 diabetes is associated with reduced prostate cancer risk

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Evaluation of association of HNF1B variants with diverse cancers: collaborative analysis of data from 19 genome-wide association studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

miRBase: integrating microRNA annotation and deep-sequencing data

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Meta-regulation: microRNA regulation of glucose and lipid metabolism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Role of microRNAs in obesity and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Targeting microRNAs in obesity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Role of microRNAs in diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Identification of microRNAs with a role in glucose stimulated insulin secretion by expression profiling of MIN6 cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Identification of glucose-regulated miRNAs from pancreatic {beta} cells reveals a role for miR-30d in insulin transcription

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

MicroRNAs in diabetes: tiny players in big disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

MicroRNA-15a positively regulates insulin synthesis by inhibiting uncoupling protein-2 expression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Identification of microRNAs expressed highly in pancreatic islet-like cell clusters differentiated from human embryonic stem cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Independent component and pathway-based analysis of miRNA-regulated gene expression in a model of type 1 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

The involvement of microRNAs in Type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Identification of MicroRNAs that control lipid droplet formation and growth in hepatocytes via high-content screening

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

microRNAs and cancer: an overview

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Targeting microRNAs in cancer: rationale, strategies and challenges

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

MicroRNAs in Cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

miRNAs and cancer: New research developments and potential clinical applications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Metastamir: the field of metastasis-regulatory microRNA is spreading

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

A role of miR-27 in the regulation of adipogenesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

MicroRNA and cancer--focus on apoptosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Role of anti-oncomirs miR-143 and -145 in human colorectal tumors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Patterns of known and novel small RNAs in human cervical cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Downregulation of microRNAs-143 and -145 in B-cell malignancies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

The expression profile of microRNAs in a model of 7,12-dimethyl-benz[a]anthrance-induced oral carcinogenesis in Syrian hamster

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Decreased expression of microRNA-143 and -145 in human gastric cancers.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

miR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

MicroRNA profiles of healthy basal and luminal mammary epithelial cells are distinct and reflected in different breast cancer subtypes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Relevance of miR-21 and miR-143 expression in tissue samples of colorectal carcinoma and its liver metastases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Modulation of microRNA processing by p53

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

MicroRNA-143 Regulates Human Osteosarcoma Metastasis by Regulating Matrix Metalloprotease-13 Expression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Characterized mechanism of alpha-mangostin-induced cell death: caspase-independent apoptosis with release of endonuclease-G from mitochondria and increased miR-143 expression in human colorectal cancer DLD-1 cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Specific microRNAs modulate embryonic stem cell-derived neurogenesis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Regulation of cyclin dependent kinase 6 by microRNA 124 in medulloblastoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Potential role of miR-9 and miR-223 in recurrent ovarian cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Expression profile of microRNAs in c-Myc induced mouse mammary tumors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

New pancreas from old: microregulators of pancreas regeneration

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Expression of islet-specific microRNAs during human pancreatic development.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

miR-335 directly targets Rb1 (pRb/p105) in a proximal connection to p53-dependent stress response.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Endogenous human microRNAs that suppress breast cancer metastasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Differential glucose-regulation of microRNAs in pancreatic islets of non-obese type 2 diabetes model Goto-Kakizaki rat

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Tumor angiogenesis: cause or consequence of cancer?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Abnormal angiogenesis in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Silencing or fueling metastasis with VEGF inhibitors: antiangiogenesis revisited

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

VEGF resistance as a molecular basis to explain the angiogenesis paradox in diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

MicroRNA-200b regulates vascular endothelial growth factor-mediated alterations in diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

miR-200b Targets Ets-1 and Is Down-regulated by Hypoxia to Induce Angiogenic Response of Endothelial Cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Role of microRNAs in drug-resistant ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

MicroRNAs in ovarian cancer biology and therapy resistance.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

A pancreatic islet-specific microRNA regulates insulin secretion

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

miR-375 targets 3'-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic beta-cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

miR-375 maintains normal pancreatic alpha- and beta-cell mass

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

MiR-322/424 and -503 are induced during muscle differentiation and promote cell cycle quiescence and differentiation by down-regulation of Cdc25A.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Systematic validation of predicted microRNAs for cyclin D1

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

NF-kappaB signaling pathway and its therapeutic implications in human diseases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

NF-kappaB: a potential target for cancer chemoprevention and therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Pro-inflammatory mechanisms in diabetic neuropathy: focus on the nuclear factor kappa B pathway

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Role of NF-kappa B in the pathogenesis of diabetes and its associated complications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

NF-κB, inflammation, and metabolic disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

miR-146a suppresses invasion of pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

microRNAs in Early Diabetic Retinopathy in Streptozotocin-Induced Diabetic Rats

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

The ZEB/miR-200 feedback loop--a motor of cellular plasticity in development and cancer?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Retracted: Up-Regulation of Sonic Hedgehog Contributes to TGF-β1-Induced Epithelial to Mesenchymal Transition in NSCLC Cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Phosphoglucose Isomerase/Autocrine Motility Factor Mediates Epithelial-Mesenchymal Transition Regulated by miR-200 in Breast Cancer Cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

MicroRNAs differentially regulated by Akt isoforms control EMT and stem cell renewal in cancer cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Loss of miR-200 Inhibition of Suz12 Leads to Polycomb-Mediated Repression Required for the Formation and Maintenance of Cancer Stem Cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

miR-200a Prevents renal fibrogenesis through repression of TGF-β2 expression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

The miR-30 family microRNAs confer epithelial phenotype to human pancreatic cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

MiR-30 family and EMT in human fetal pancreatic islets

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Evidence for epithelial-mesenchymal transition in adult human pancreatic exocrine cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

TGF-beta1-induced epithelial-to-mesenchymal transition and therapeutic intervention in diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Anti-Tumor Activity of a Novel Compound-CDF Is Mediated by Regulating miR-21, miR-200, and PTEN in Pancreatic Cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Implication of microRNAs in drug resistance for designing novel cancer therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Serum microRNAs as non-invasive biomarkers for cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Diabetes mellitus type 2 - an independent risk factor for cancer?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Type 2 diabetes and cancer: what is the connection?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Substantially increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis of epidemiologic evidence in Japan

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2011.00906.X

21 January 2018

Identifiers

10.1111/J.1467-789X.2011.00906.X

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37902256&oldid=2118785348"